Xaviat 10 mg Tablet
PDF Leaflet Revision Date: 22 December 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Prevention of venous thromboembolism in major orthopaedic surgery.
Dosage (summary)
One tablet (10 mg) once daily, starting 6-10 hours post-surgery.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding due to potential risks.
Key Drug Interactions
- CYP3A4 inhibitors (e.g., ketoconazole, ritonavir)
- Other anticoagulants
- NSAIDs
Contraindications
- Hypersensitivity to rivaroxaban
- Active bleeding
- Significant hepatic disease
- Concomitant anticoagulants
Common side effects
- Bleeding
- Dizziness
- Gastrointestinal bleeding
Counselling Points
- Take with or without food
- Report any signs of bleeding
- Avoid pregnancy during treatment
Serious warnings
- Increased risk of bleeding
- Monitor for signs of bleeding
- Use with caution in renal impairment
Important Disclaimer
The Xaviat 10 mg Tablet professional information leaflet below is the property of Viatris Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
